Research records indexed for GHRP-6

This page carries 12 of the 699 records that the literature query returned for GHRP-6, selected by citation count and preferring records that name the compound in their title. It is a selection, not a complete index, and the 687 records it does not carry are not represented here. Every row resolves to a real identifier and names the study model, so no finding reads as a human claim by default. The compound page is GHRP-6.

Indexed records

Records retrieved for GHRP-6, newest first
RecordYearStudy typeModeln as statedWhat it reported
Molecular recognition of an acyl-peptide hormone and activation of ghrelin receptor pmid:344174682021Research Support, Non-U.S. Gov't, research-articleotherNot statedIndexed as research support, non-u.s. gov't, research-article. compound named in the abstract, not the title. study model from MeSH "Animals" with no rodent species heading. subject headings: Cell Line; GTP-Binding Protein Alpha Subunits, Gq-G11; Oligopeptides; Cryoelectron Microscopy; Binding Sites.
Ghrelin attenuates oxidative stress and neuronal apoptosis via GHSR-1α/AMPK/Sirt1/PGC-1α/UCP2 pathway in a rat model of neonatal HIE pmid:312790912019Research Support, Non-U.S. Gov't, research-articlerodentNot statedIndexed as research support, non-u.s. gov't, research-article. compound named in the abstract, not the title. study model from MeSH "Rats". subject headings: Neurons; Animals, Newborn; Hypoxia-Ischemia, Brain; Disease Models, Animal; Protein Kinases.
The protective effects of Ghrelin/GHSR on hippocampal neurogenesis in CUMS mice pmid:311036172019Research Support, Non-U.S. Gov'trodentNot statedIndexed as research support, non-u.s. gov't. compound named in the abstract, not the title. study model from MeSH "Mice, Inbred C57bl". subject headings: Hippocampus; Cells, Cultured; Mice, Inbred C57BL; Mice, Knockout; Chronic Disease.
Growth hormone secretagogue receptor signalling affects high-fat intake independently of plasma levels of ghrelin and LEAP2, in a 4-day binge eating model pmid:314691952019Research Support, Non-U.S. Gov'trodentNot statedIndexed as research support, non-u.s. gov't. compound named in the abstract, not the title. study model from MeSH "Mice". subject headings: Triazoles; Glycine; Antimicrobial Cationic Peptides; Oligopeptides; Bulimia.
Ghrelin alleviates anxiety- and depression-like behaviors induced by chronic unpredictable mild stress in rodents pmid:282459762017Research Support, Non-U.S. Gov'trodentNot statedIndexed as research support, non-u.s. gov't. compound named in the abstract, not the title. study model from MeSH "Mice, Inbred C57bl". subject headings: Hippocampus; Mice, Inbred C57BL; Rats, Sprague-Dawley; Oligopeptides; Behavior, Animal.
Azapeptide Synthesis Methods for Expanding Side-Chain Diversity for Biomedical Applications pmid:285985972017Research Support, Non-U.S. Gov'totherNot statedIndexed as research support, non-u.s. gov't. compound named in the abstract, not the title. study model from assigned MeSH headings do not state a study model. subject headings: Aza Compounds; Amino Acids; Peptides; Cyclization.
The effects of ghrelin antagonists [D-Lys(3) ]-GHRP-6 or JMV2959 on ethanol, water, and food intake in C57BL/6J mice pmid:252572922014Research Support, Non-U.S. Gov't, research-articlerodentNot statedIndexed as research support, non-u.s. gov't, research-article. study model from MeSH "Mice, Inbred C57bl". subject headings: Mice, Inbred C57BL; Ethanol; Triazoles; Glycine; Oligopeptides.
Comparison of the gastroprokinetic effects of ghrelin, GHRP-6 and motilin in rats in vivo and in vitro pmid:158903362005Comparative Study, Research Support, Non-U.S. Gov'trodentNot statedIndexed as comparative study, research support, non-u.s. gov't. study model from MeSH "Rats". subject headings: Stomach; Gastric Fundus; Pyloric Antrum; Rats, Wistar; Guanethidine.
Regulation of Pit-1 expression by ghrelin and GHRP-6 through the GH secretagogue receptor pmid:115187972001Research Support, Non-U.S. Gov'trodentNot statedIndexed as research support, non-u.s. gov't. study model from MeSH "Rats". subject headings: Pituitary Gland, Anterior; Cells, Cultured; Animals, Newborn; Cycloheximide; Dactinomycin.
Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level pmid:78838541995Research Support, Non-U.S. Gov'totherNot statedIndexed as research support, non-u.s. gov't. study model from MeSH "Humans" with no interventional publication type. subject headings: Hypothalamus; Hypothalamic Diseases; Pituitary Diseases; Growth Hormone; Oligopeptides.
Central effects of growth hormone-releasing hexapeptide (GHRP-6) on growth hormone release are inhibited by central somatostatin action pmid:77384791995Journal ArticleotherNot statedIndexed as journal article. study model from MeSH "Animals" with no rodent species heading. subject headings: Hypothalamus; Guinea Pigs; Tetrazoles; Benzazepines; Octreotide.
Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity pmid:84733891993Research Support, Non-U.S. Gov'totherNot statedIndexed as research support, non-u.s. gov't. study model from MeSH "Humans" with no interventional publication type. subject headings: Pituitary Gland, Anterior; Obesity; Pyridostigmine Bromide; Growth Hormone; Oligopeptides.

Where this page sits

Compound page: GHRP-6. Class: Growth hormone secretagogues.

Retrieved 2026-10-10.

Sources

  1. PubChem Compound Summary for CID 4345065, Ghrp-6. PubChem, National Library of Medicine (2026). pubchem:4345065
  2. Drugs@FDA application register query for this compound, no application records returned. U.S. Food and Drug Administration, openFDA drugsfda endpoint (2026). fda:ghrp-6
  3. Regulation of Pit-1 expression by ghrelin and GHRP-6 through the GH secretagogue receptor. Mol Endocrinol (2001). pmid:11518797
  4. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity. J Clin Endocrinol Metab (1993). pmid:8473389
  5. Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level. J Clin Endocrinol Metab (1995). pmid:7883854
  6. Comparison of the gastroprokinetic effects of ghrelin, GHRP-6 and motilin in rats in vivo and in vitro. Eur J Pharmacol (2005). pmid:15890336
  7. The effects of ghrelin antagonists [D-Lys(3) ]-GHRP-6 or JMV2959 on ethanol, water, and food intake in C57BL/6J mice. Alcohol Clin Exp Res (2014). pmid:25257292

On each stated value was matched to the record cited for it. That is record matching, not an appraisal of the research. Compiled and checked by: Peptide Monographs editorial desk. No qualified clinical reviewer.

Related resources